| DC Field | Value | Language |
|---|
| dc.contributor.author | Netrebenko, A. S. | - |
| dc.date.accessioned | 2023-10-03T11:52:31Z | - |
| dc.date.available | 2023-10-03T11:52:31Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Netrebenko, A.S. Correction of renal ischemia/reperfusion injury with the Combination of Infliximab and the erythropoietin-derived peptide mimetic pHBSP / A.S. Netrebenko // Research Results in Pharmacology. - 2023. - Vol.9, №2.-P. 85-97. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/56830 | - |
| dc.description.abstract | The renoprotective activity of the helix B-derived erythropoietin peptide and infliximab has been confirmed, and the advantage of their combined administration for the correction of morphofunctional disorders in simulated renal ischemia/reperfusion injury due to the multimodal effect on pathogenetic processes has been established | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | pHBSP | ru |
| dc.subject | infliximab | ru |
| dc.subject | renal ischemia/reperfusion | ru |
| dc.subject | TNF-α | ru |
| dc.subject | preconditioning | ru |
| dc.subject | inflammation | ru |
| dc.title | Correction of renal ischemia/reperfusion injury with the Combination of Infliximab and the erythropoietin-derived peptide mimetic pHBSP | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 2
|
